Enveric Biosciences Files 8-K on Shareholder Votes & Exhibits
Ticker: ENVB · Form: 8-K · Filed: Dec 11, 2025 · CIK: 890821
| Field | Detail |
|---|---|
| Company | Enveric Biosciences, Inc. (ENVB) |
| Form Type | 8-K |
| Filed Date | Dec 11, 2025 |
| Risk Level | low |
| Pages | 3 |
| Reading Time | 4 min |
| Key Dollar Amounts | $0.01 |
| Sentiment | neutral |
Sentiment: neutral
Topics: 8-K, corporate-actions, financial-disclosures
TL;DR
Enveric Biosciences filed an 8-K on 12/11/25 covering shareholder votes and financial exhibits.
AI Summary
Enveric Biosciences, Inc. filed an 8-K on December 11, 2025, reporting on matters submitted to a vote of security holders and financial statements/exhibits. The company, incorporated in Delaware, is located at 245 First Street, Riverview II, 18th Floor, Cambridge, MA 02142.
Why It Matters
This filing indicates important corporate actions and financial disclosures are being made public by Enveric Biosciences.
Risk Assessment
Risk Level: low — This is a routine filing for corporate actions and financial disclosures, not indicating immediate financial distress or significant operational changes.
Key Players & Entities
- Enveric Biosciences, Inc. (company) — Registrant
- 0001493152-25-027196 (filing_id) — Accession Number
- 20251211 (date) — Filing Date
- 245 First Street, Riverview II, 18th Floor, Cambridge, MA 02142 (address) — Principal Executive Offices
FAQ
What specific matters were submitted to a vote of security holders?
The filing indicates that matters were submitted to a vote of security holders, but the specific details of these matters are not provided in the excerpt.
What type of financial statements and exhibits are included in this filing?
The filing states that 'Financial Statements and Exhibits' are included, but the specific content of these is not detailed in the provided text.
When was Enveric Biosciences, Inc. incorporated?
Enveric Biosciences, Inc. was incorporated in Delaware.
What is the principal executive office address for Enveric Biosciences, Inc.?
The principal executive office is located at 245 First Street, Riverview II, 18th Floor, Cambridge, MA 02142.
What is the SEC file number for Enveric Biosciences, Inc.?
The SEC file number for Enveric Biosciences, Inc. is 001-38286.
Filing Stats: 1,035 words · 4 min read · ~3 pages · Grade level 11.3 · Accepted 2025-12-11 12:41:05
Key Financial Figures
- $0.01 — ch registered Common stock, par value $0.01 per share ENVB The Nasdaq Stock Mar
Filing Documents
- form8-k.htm (8-K) — 55KB
- 0001493152-25-027196.txt ( ) — 220KB
- envb-20251211.xsd (EX-101.SCH) — 3KB
- envb-20251211_lab.xml (EX-101.LAB) — 33KB
- envb-20251211_pre.xml (EX-101.PRE) — 22KB
- form8-k_htm.xml (XML) — 4KB
SIGNATURES
SIGNATURES Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized. Date: December 11, 2025 ENVERIC BIOSCIENCES, INC. By: /s/ Joseph Tucker Joseph Tucker Chief Executive Officer